Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses.

Literature DB >> 12435716

In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses.

Ingo Sobottka¹, Georg Cachovan, Enno Stürenburg, M Oliver Ahlers, Rainer Laufs, Ursula Platzer, Dietrich Mack.

Abstract

We evaluated the antimicrobial susceptibility of 87 pathogens isolated from 37 patients with odontogenic abscesses. The most prevalent bacteria were viridans group streptococci and Prevotella species. Considering all bacterial isolates, 100% were susceptible to amoxicillin-clavulanic acid, 98% were susceptible to moxifloxacin and to levofloxacin, 76% were susceptible to doxycycline, 75% were susceptible to clindamycin, and 69% were susceptible to penicillin.

Entities: Chemical Species

Mesh：

Substances：

Year: 2002 PMID： 12435716 PMCID： PMC132736 DOI： 10.1128/AAC.46.12.4019-4021.2002

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

19 in total

Review 1. Evaluation of the clinical microbiology profile of moxifloxacin.

Authors: C Krasemann; J Meyer; G Tillotson
Journal: Clin Infect Dis Date: 2001-03-15 Impact factor: 9.079

2. Antibiotics and the intraoral abscess.

Authors: S Epstein; I W Scopp
Journal: J Periodontol Date: 1977-04 Impact factor: 6.993

3. The microbiology and management of acute dentoalveolar abscess: views of British oral and maxillofacial surgeons.

Authors: Y Gill; C Scully
Journal: Br J Oral Maxillofac Surg Date: 1988-12 Impact factor: 1.651

4. Odontogenic infections.

Authors: W Guralnick
Journal: Br Dent J Date: 1984-06-23 Impact factor: 1.626

5. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.

Authors: C A Peloquin; T J Cumbo; D E Nix; M F Sands; J J Schentag
Journal: Arch Intern Med Date: 1989-10

6. Past administration of beta-lactam antibiotics and increase in the emergence of beta-lactamase-producing bacteria in patients with orofacial odontogenic infections.

Authors: T Kuriyama; K Nakagawa; T Karasawa; Y Saiki; E Yamamoto; S Nakamura
Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Endod Date: 2000-02

7. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections.

Authors: T Kuriyama; T Karasawa; K Nakagawa; Y Saiki; E Yamamoto; S Nakamura
Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Endod Date: 2000-11

Review 8. Orofacial odontogenic infections.

Authors: A W Chow; S M Roser; F A Brady
Journal: Ann Intern Med Date: 1978-03 Impact factor: 25.391

9. The clinical significance of beta hemolytic streptococci of the milleri group in oral abscesses.

Authors: N J Schuman; J E Turner
Journal: J Clin Pediatr Dent Date: 1999 Impact factor: 1.065

10. Treatment of orofacial infections of odontogenic origin.

Authors: A Heimdahl; C E Nord
Journal: Scand J Infect Dis Suppl Date: 1985

11 in total

1. Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions.

Authors: P Diz Dios; I Tomás Carmona; J Limeres Posse; J Medina Henríquez; J Fernández Feijoo; M Alvarez Fernández
Journal: Antimicrob Agents Chemother Date: 2006-09 Impact factor: 5.191

Review 2. Microbiology and treatment of acute apical abscesses.

Authors: José F Siqueira; Isabela N Rôças
Journal: Clin Microbiol Rev Date: 2013-04 Impact factor: 26.132

3. [Critical odontogenic infection involving the mediastinum. Case report].

Authors: M S Bartsch; W von Bernstorff; F K W Schäfer; J Wiltfang; P H Warnke
Journal: Mund Kiefer Gesichtschir Date: 2005-07

4. Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial.

Authors: Georg Cachovan; Rainer H Böger; Ina Giersdorf; Olaf Hallier; Thomas Streichert; Munif Haddad; Ursula Platzer; Gerhard Schön; Karl Wegscheider; Ingo Sobottka
Journal: Antimicrob Agents Chemother Date: 2010-12-20 Impact factor: 5.191

5. Development of osteomyelitis following dental abscesses-influence of therapy and comorbidities.

Authors: Julius Moratin; Christian Freudlsperger; Karl Metzger; Caroline Braß; Moritz Berger; Michael Engel; Jürgen Hoffmann; Oliver Ristow
Journal: Clin Oral Investig Date: 2020-07-07 Impact factor: 3.573

6. Bacterial colonization of microbial biofilms in oral squamous cell carcinoma.

Authors: J Bolz; E Dosá; J Schubert; A W Eckert
Journal: Clin Oral Investig Date: 2013-06-22 Impact factor: 3.573

7. Microbiological analysis of a prospective, randomized, double-blind trial comparing moxifloxacin and clindamycin in the treatment of odontogenic infiltrates and abscesses.

Authors: Ingo Sobottka; Karl Wegscheider; Ludwig Balzer; Rainer H Böger; Olaf Hallier; Ina Giersdorf; Thomas Streichert; Munif Haddad; Ursula Platzer; Georg Cachovan
Journal: Antimicrob Agents Chemother Date: 2012-02-21 Impact factor: 5.191

8. Osteomyelitis of the jaw: resistance to clindamycin in patients with prior antibiotics exposure.

Authors: C Pigrau; B Almirante; D Rodriguez; N Larrosa; S Bescos; G Raspall; A Pahissa
Journal: Eur J Clin Microbiol Infect Dis Date: 2008-09-17 Impact factor: 3.267

9. Fabrication and Appraisal of Poly (Lactic-Co-Glycolic Acid) - Moxifloxacin Nanoparticles using Vitamin E-TPGS: A Potential Intracanal Drug Delivery Agent.

Authors: Hardik Makkar; Gaurav Patri
Journal: J Clin Diagn Res Date: 2017-06-01

10. Antibiotic prescription in the treatment of odontogenic infection by health professionals: a factor to consensus.

Authors: Raquel González-Martínez; Isidoro Cortell-Ballester; José-María Herráez-Vilas; José-María Arnau-de Bolós; Cosme Gay-Escoda
Journal: Med Oral Patol Oral Cir Bucal Date: 2012-05-01